Pegfilgrastim
PFS: 6mg/0.5 mL; 6 mg/0,6 mL
A synthetic version of an intrinsic factor in human body which helps bone marrow production of new white blood cells. Filgrastim is given to people whose ability to produce white blood cells is reduced, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation. Peg- filgrastim has a polyethylene glycol (PEG) unit add to make the molecule larger and extend the retention time when injecting.
Filgratism
PFS: 30 MU/0,5 Ml: 48 MU/0,8 mL
Vial: 30 MU/1 mL; 48 MU/1.6 mL
A synthetic version of an intrinsic factor in human body which helps bone marrow production of new white blood cells. Filgrastim is given to people whose ability to produce white blood cells is reduced, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation. It is also used in certain treatment procedure such as bone marrow or stem cell transplant.
Peginterferon alfa 2a
PFS: 180 mcg/0.5 mL
Vial: 180 mcg/1 mL
An antiviral for the treatment of chronic hepatitis B virus (HBV) infection and chronic hepatitis C virus (HCV) infection. HBV and HCV infections are HIV related opportunistic infections. Peg-Interferon alfa-2a has a polyethylene glycol (PEG) unit add to make the molecule larger and extend the retention time when injecting.
Interferon alfa 2a
PFS: 3 MIU/0.5 mL
Vial: 3 MIU/1 mL
An antiviral for the treatment of chronic hepatitis B virus (HBV) infection and chronic hepatitis C virus (HCV) infection. HBV and HCV infections are HIV related opportunistic infections. IFN alfa-2a is given alone or in combination with other medications.
Erythropoietin Alfa
PFS: 2,000 IU/0.5 mL; 4,000 IU/0.5 mL; 10,000 IU/1 mL
Vial: 2,000 IU/1 mL; 4,000 IU/1 mL; 10,000 IU/1 mL
EPO is used to treat anemia in patient with chronic kidney failure, patient receiving HIV treatment, and patient receiving chemotherapy for some types of cancer. It also be used in anemic patients to reduce the need for blood transfusions surgeries that have a high risk of blood loss.
Trastuzumab
Vial: 150 mg; 440 mg
A monoclonal antibody used to treat breast cancer. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection under the skin. FACEPTOR is in clinical trials.
Darbepoetin alfa
PFS: 10 mcg/0.4 mL; 40 mcg/0.4 mL; 60 mcg/0.3 mL; 100mcg/0.5 mL.
STIMUS (Darbepoetin alfa) is a biosimilar that is in clinical trials at some hospitals in Vietnam. STIMUS is an ETC product used to treat anemia in patient with chronic kidney failure and patient receiving chemotherapy for some types of cancer. With satisfactory results in clinical trial, we expect to launch STIMUS in the marketplace in 2021.
Vial: 100 mg/10 mL; 500 mg/50 mL
A monoclonal antibody which targets a protein called CD20 on the surface of the leukaemia and lymphoma cells. It is used to treat certain autoimmune diseases and types of cancer: non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis...
Human Insulin
100 IU/mL
A short-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes.
Products:
1. Maropin R (vial 10 mL): Insulin Regular, short-acting
2. Maropin N (vial 10 mL): Insulin NPH, intermediate acting
3. Maropin 30/70 (vial 10 mL and pen 3 mL): 30% Insulin R and 70% Insulin isophane
Insulin Glargine
Vial: 10 mL
Pen: 3 mL
A long-acting insulin, used in the management of type I and type II diabetes. It acts longer than regular insulin, providing a low, steady level of insulin. Insulin glargine may be used with a shorter-acting insulin product. It may also used alone or with other diabetes drugs.
